Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 220 - файл

.pdf
Скачиваний:
0
Добавлен:
28.08.2026
Размер:
86 Мб
Скачать
88
https://t.me/medicina_free
4 Acute Abdomen-Induced Preterm Labor
ab
Fig. 4.7 (a) Uteroplacental apoplexy means extravasa- tion of blood into the uterus myometrium, and serosa. (b) Blood clots adherent to the placenta (arrows) indicates
4.3.3.3 Trauma-induced Preterm Labor
Placental Abruption
See Sect. 25.3.6.1.
Traumatic Uterine Contractions
Uterine contractions induced by uterine trauma are the result of two processes. First is when a traumatic uterine injury destabilizes lysosomal enzymes that can initiate prostaglandin produc­tion. Second, thrombin produced by actively clot­ting blood interacts with the protease-activated receptors in the myometrium, resulting in robust uterus contractions, even without prostaglandin production [118]. Thrombin at concentrations 1–100U/mL represents less thrombin generated by 1mL of clotting blood and stimulates myome­trial contractions in a dose-dependent fashion. Thrombin activates the phosphatidylinositol sig­naling pathway and generates cytosolic calcium oscillations [119].
Maternal demographic factors, presence of uterine contractions, maternal clinical conditions (abdominal pain, abdominal tenderness, vaginal bleeding), hematologic and coagulation studies, US ndings, fetal heart rate tracing category, AIS score for abdomen, and ISS score do not predict preterm delivery or other secondary outcomes [120].
abruptio placentae caused by uteroplacental apoplexy. (Reproduced with permission from [111])
4.3.4 Maternal Nutritional Status
Many causes of fetal morbidity, in addition to PTL, are due to the loss of adequate maternal nutrition during pregnancy. A low prepregnancy BMI is associated with a high risk of spontaneous PTB, whereas obesity can be protective [121]. Women with low serum iron, folate, or zinc have more PTB [122, 123]. Maternal thinness is asso­ciated with decreased blood volume and reduced uterine blood ow, increasing the rate of PTL [124].
The acute abdomen during pregnancy results in three scenarios of prolonged maternal starva­tion as follows:
• recurrent or persistent symptomatology of
underlying disease such as symptomatic
cholelithiasis/cholecystitis, acute/chronic pan-
creatitis, adnexal torsion, etc.,
• postoperative catabolism with inadequate IV
supplementation,
• protracted posttreatment sepsis/septic shock.
Peroral nutrition is inadequate mainly due to a higher basal metabolism in systemic inamma­tion leading to body mass loss in all these sce­narios. Due to blood redistribution in sepsis, uterine blood ow can further be decreased.
Preterm Labour: Pathogenesis & Maternal Complications
4.4 Clinical Presentation
https://t.me/medicina_free
89
Cervical
Procedures
Removing part of
the cervix
Ex. Cone biopsy,
cervical LEEP
cervical
stroma &
cervical
scarring
tensile
strength
and
plasticity
Cervical Insufficiency
effacement (thinning)
Authors: Skye Russell Reviewers: Danielle Chang,
Crystal Liu, Yan Yu*, Nicholas Papalia* *MD at time of publication
Legend:
cervical
glands
mucous production
risk of infection
inflammation
prostaglandins
Cervical collagen
degradation
Pathologic cervical
dilation and/or
Genitourinary
Infections
E.g. Urinary tract
infection, bacterial
vaginosis, chorioamnionitis, abnormal vaginal
flora
bacterial
colonization
of fetal
membrane
bacterial
enzymes and
immune
reactions
Rupture of Membranes
Antepartum
Hemorrhage
risk
placental abruption
decidual
tissue factor
release
Activates
coagulation
cascade
thrombin
proteases
Digest and weaken
amniotic membrane
Preterm Premature
Uterine contractions and cervical change occurring <37wk gestational age
Risk of future preterm labour and preterm birth
Substance
Use
Smoking or
cocaine
use
Vasoconstriction
in uterine circulation, endothelial
dysfunction
Placental
hypoperfusion
and ischemia
fetal ACTH
placental
prostaglandins
myometrial
sensitivity to oxytocin
Uterine contractions
Preterm Labour
ComplicationsSign/Symptom/Lab Finding MechanismPathophysiology
Maternal
Stress
Malnutrition,
depression,
trauma­related
disorders,
work-related
stress
cortisol
placental
corticotropin
releasing
hormone
Uterine
Abnormalities
Mullerian duct anomalies:
congenital abnormalities in
uterine shape
Septate uterus: ridge of tissue
dividing uterus into two horns
Intracavitary leiomyoma:
benign mass inside uterus
Rapid growth
exceeds blood
supply
lschemia & necrosis
of fetal tissue
prostaglandins
and cytokines
Uterine
volume
functional
volume of
uterine cavity
Uterine stretch
Upregulation of
oxytocin receptors
Abbreviations:
• LEEP – Loop electrosurgical
excision procedure
• ACTH – adrenocorticotropic hormone
Multifetal
pregnancy,
poly-
hydramnios
Maternal
Genome
Family hx or
personal hx of
preterm birth,
previous
preterm premature rupture of
membrane
Genes for
risk
Mechanism
unknown
Fig. 4.8 Pathogenesis of preterm delivery. (Reproduced with permission from [129])
4.3.5 Final Common Pathway
inammation, abruption, and excess stretch
occurring before 24weeks present as “incom­The generation of prostaglandins and proteases reects the nal common delivery pathway, preterm or at term. Prostaglandin levels increase in reproductive tract tissues, maternal plasma, and amniotic uid immediately before
petent cervix” with or without subsequent
PPROM and not PTL.Figure4.8 presents the
discrete pathogenic processes leading to pre-
maturity and their nal common biochemical
pathway. and during parturition [125, 126]. Concurrent with rising prostaglandin levels is the upregu­lation of myometrial prostaglandin receptors
4.4 Clinical Presentation
before labor onset [127, 128]. Prostaglandins induce functional progesterone withdrawal, enhance sensitivity to estrogens, and increase MMP and IL-8 expression. Moreover, all the pathways of prematurity described above also directly trigger MMP and IL-8 expression to mediate cervical change and fetal membrane rupture. The myometrium is quiescent before 20weeks’ gestation because of the high PR-B, low ER-α, low circulating estrogen levels, and inhibition of CAP gene expression. Therefore,
Clinical presentation of acute abdomen warrants
a search of its cause and other potential causes of
PTL. For pregnant patients with abdominal
trauma, maternal hemodynamic status should be
checked rst (see Chap. 25), then the cause of
acute abdomen and PTL should be evaluated.
Sometimes a clinical picture is challenging to
establish due to attenuated inammatory
response. Several authors observed this in the late
nineteenth century [130].
90
https://t.me/medicina_free
4 Acute Abdomen-Induced Preterm Labor
One-third of all patients with PTL have intact membranes, one-third present with PPROM, and one-third result from indicated delivery (delivery in response to maternal or fetal complications) [131].
Diagnosis of ROM is made by sterile vaginal examination by speculum in women presenting with a suspicious clinical history or US detected oligohydramnios. Conrmation of vaginal lacer­ations or bony fragments may indicate pelvic fractures. Evident uid passing through the cervi­cal os is diagnostic.
For the presentation of traumatic placental abruption, see Sect. 25.3.6.1.
4.5 Diagnosis
4.5.1 Prediction ofPreterm Labor
4.5.1.1 Uterine Contractions
Intrauterine infection is associated with uterine contraction frequency or PTL [132134]. However, uterine contractions do not predict PTL well in singletons because of the wide variation in frequency in normal pregnancy and PTL [134]. Similar results were found in twins [135]; how­ever, women admitted with a diagnosis of PTL, if they do not deliver, remain at increased risk of subsequent PTL and PPROM.
4.5.1.2 Laboratory Findings
A marked correlation of elevated CRP and ALP in women with non-acute abdomen PTL was observed compared to women without PTL, whereas the best cut-off values of CRP >20– 27mg/L and ALP >300–399IU/L were the best values in the prediction of PTL [136, 137]. Currently, no studies predict PTL in pregnant patients with acute abdomen.
Most patients with acute abdomen have
elevated CRP values and are at increased
risk for PTL.
4.5.1.3 Transvaginal Ultrasound
Transvaginal US has shown that a short cervix (cervical length 25mm) is associated with IAI and an increased risk of adverse pregnancy out­comes [83, 138]. Women with a cervical length of 15mm between 22 and 30weeks of gesta­tion have a higher rate of microbial invasion of the amniotic cavity and are more likely to deliver spontaneously before 35 weeks of gestation [139]. Therefore, the US cervical length may be a valuable predictor of the risk of microbial inva­sion of the amniotic cavity and IAI [83]. Unfortunately, there are no studies in patients with localized/diffuse peritonitis or abdominal trauma when PTL develops quickly, in hours or days.
4.5.2 Preterm Premature Rupture ofMembranes
The presence of vaginal bleeding outside the rst trimester has been associated with a sevenfold increase in the risk of PROM and a 2.9-fold increased risk of PTB [96].
An alkaline vaginal pH (6.0–6.5) and a “fern­ing” pattern on microscopic examination of dried vaginal secretions are supportive (normal vaginal secretions have a pH of 5.0, whereas amniotic uid has a pH of 7.0) when visual inspection is equivocal. False-positive ndings are due to cer­vical mucus, blood, semen, alkaline antiseptics, or bacterial vaginosis. False-negative results are from prolonged leakage and oligohydramnios. Repeat speculum examination after prolonged bed rest may provide diagnostic information if initial testing is negative despite a suspicious his­tory. In the absence of fetal growth restriction or urogenital abnormalities, US evidence of oligohydramnios is suggestive but not diagnostic of ROM. The diagnosis can be conrmed by indigo carmine amnioinfusion with the transvagi­nal passage of dye. A search for concomitant maternal and fetal injuries is mandatory, and pro­longed continuous fetal monitoring is advocated.
4.6 Treatment
https://t.me/medicina_free
91
4.5.3 Placental Pathology
Placental pathology has a better predictive value for IAI than clinical signs and symptoms. Placental histology has a high negative predictive value (97%) and reasonable positive predictive value (79%) for diagnosing IAI compared with uid cultures [140]. Placental pathology has a twofold improvement in positive predictive value compared with the clinical signs and symptoms of IAI [141]. Unfortunately, placental pathology can be obtained when the patients’ management has been completed without inuencing the immediate therapeutic process.
4.6 Treatment
With extrauterine intra-abdominal infection, the underlying cause and the PTL should be treated simultaneously. With maternal abdominal trauma, the mother should be stabilized rst (see Chap. 25), then PTL treated.
The vast majority (70–80%) of the women with symptoms of all-cause spontaneous PTL do not deliver preterm even without intervention. The most common criteria for PTL are uterine contractions (4/20 min or 8/h) and cervical change with intact membranes at 20–36 weeks 6days.
Women without cervical change do not
have PTL and should not receive tocolysis.
Women with PTL but negative fFN and
TVU CL 30 mm have a less than 1%
chance of delivering within 1week and a
more than 95% chance of delivering
35 weeks without therapy [142] and
should not receive tocolysis.
The complete diagnostic-therapeutic algo­rithm is presented in Fig.4.9.
In infection-induced PTL prevention, thera­peutics should ideally eliminate the microorgan-
Fig. 4.9 Suggested algorithm for evaluating and managing threatened preterm labor. () negative, (+) positive, CL cervical length, fFN fetal bronectin, PTB preterm birth. (Reproduced with permission from [143])
CL <20 mm
Admit for tocolysis,
steroids. magnesium
sulfate for
neuroprotection, etc.
Shortening >5mm
Consider admission,
tocolysis and steroids,
especially if prior PTB
Threatened
preterm labor
0/7
6/7
23
-33
weeks
Obtain fFN prior to digital
exam and vaginal CL
TransvaginalCL
CL >20 – 30 mm
fFN + fFN -
Repeat CL in 2-6
hours if persistent
contractions
-Stable CL and no prior PTB routine care
-Stable CL <25mm and/or prior PTB consider vaginal proge sterone, repeat CL
in 1 week
(repeat CL for
persistent/recurrent
CL >30 mm
Discharge
contractions)
92
https://t.me/medicina_free
4 Acute Abdomen-Induced Preterm Labor
isms from the amniotic cavity and block the ensuing cytokine cascade that drives the release of PGs and matrix metalloproteinases (MMPs), prevent the onset of PTL, and minimize the risk of FIRS.
Thirty-four weeks of gestation is a thresh­old at which perinatal morbidity and mor­tality are too low to justify the potential maternal and fetal complications and costs associated with the inhibition of labor and short-term delivery delay [144, 145]. Tocolytics are not indicated before viabil­ity (23–24weeks of gestation) since these drugs do not delay delivery for more than a few days [146].
One explanation for the inefcient longer delay of PTB is that most interventions are directed on only one of many perplexing path­ways of the complex process of parturition (see Sect. 4.2).
4.6.1 Nontocolytic Treatment
4.6.1.1 Bed Rest
Bed rest has never been tested in singleton gesta­tions complicated by PTL or PPROM. In twin pregnancies with cervical dilatation, bed rest in the hospital has not been shown to decrease PTL [147].
4.6.1.2 Antibiotics
The lack of antibiotic effectiveness in all-cause PTB may be the result of (1) a therapeutic appli­cation long after the infection is established [148], (2) the difculties in identifying the spe­cic pathogens and prescription of the pathogen­specic therapy, (3) an increase in PTB in some subgroups [149], and 4) potential adverse effects on neonatal outcomes.
Intrauterine Infection
Antibiotics are given to women with intrauterine infection-induced PTL. However, it is not the infection but the subsequent inammation that
initiates PTL and is primarily responsible for adverse neonatal outcomes. An exception is an improvement in women with PPROM with anti­biotics such as erythromycin. These results include increased latency before labor and improved neonatal outcomes [150, 151].
Compared with metronidazole, clindamycin has similar activity against anaerobes. However, it is far superior concerning broad-spectrum activity, group B streptococcus (associated with PTL when present as heavy colonization), and many other bacterial vaginosis-related organ­isms, particularly fastidious organisms such as M. hominis [152, 153]. Also, clindamycin has anti-inammatory properties [154, 155]. There is merit in oral and intravaginal administration of clindamycin to eradicate abnormal genital tract ora/bacterial vaginosis in pregnancy. Vaginal administration delivers the highest con­centration of antibiotics to the site of the heavi­est bacterial load. On the other hand, bacterial vaginosis could be associated with subclinical endometritis [156], so if vaginal organisms have already gained access to the choriodecidua, these organisms may not be accessible to vagi­nal administration. Therefore, systemic therapy may provide benets. There are no studies on the combined use of oral and vaginal clindamy­cin. Even if this reverts to normal, abnormal genital tract ora in early pregnancy is still associated with LM and PTB.This suggests that whatever damage is done by infection/inam­mation occurs early and persists [157]. Suppose antibiotics are used late in pregnancy when inammatory tissue damage may have already occurred, with irreversible changes in the cer­vix, myometrium, decidua, placenta, and extra­placental membranes. In that case, antibiotics are unlikely to be benecial [158, 159]. Unfortunately, some of these studies were not adequate.
The immune system is primed in utero and modied after birth. Accordingly, antibiotics dur­ing pregnancy or the neonatal period may disrupt the developing neonatal gut microbiome, failing immune response maturation, resulting in asthma, allergy, and atopic disease [160163]. This has led to new diets and gut microora treatments for newborns.
4.6 Treatment
https://t.me/medicina_free
93
Acute Abdomen
Studies on antibiotic prevention of infection­induced PTL did not include pregnant patients with extrauterine intra-abdominal infection (IAI). The general recommendations are:
• removal of the infective source with dosage and duration of antibiotic ther­apy as indicated by guidelines for the treatment of the primary infective cause, not for the prevention of uterine con­tractions and PTL,
• IV clindamycin, in addition to other antibiotics indicated for patients with acute abdomen or abdominal trauma with unknown group B Streptococcus culture status (especially before 32 weeks of pregnancy), should be administered.
Abdominal trauma patients are a specic subgroup because infection-induced PTL is not the primary mechanism. Antibiotic treatment of all women with threatened PTL to prevent neonatal infection with group B streptococcus is recommended because preterm infants have an increased risk of this infection [164]. Rates of neonatal group B streptococcus infection and corresponding mortality rates have declined since this strategy was adopted in the USA [164]. Preterm infants with traumatic injuries and possible hemodynamic instability (due to maternal hemorrhagic shock) or blood loss are particularly susceptible to neonatal infections.
4.6.1.3 Antioxidants
In vitro studies indicate that vitamins C and E can prevent tissue damage to chorioamniotic membranes inicted by hypochlorous acid, a reactive oxygen species produced by host cells during infection and inammation [165]. Although the dose-response relationship between the plasma ascorbic acid concentration and the prevalence of PPROM has been shown,
ascorbic acid concentrations may have only reected the general nutritional status of patients [166]. The issue is that studies focused on sin­gle, for example, hypochlorous acid-induced damage [165], whereas in vivo infection­induced damage could occur via nonoxidative pathways (e.g., elastase, protease). The diet alone could be an inadequate source of vitamins C and E during pregnancy, and supplementation may reduce PPROM [167]. Supplemental intake of vitamins C and E to prevent preeclampsia did not lower PTB and PPROM rates, but respira­tory morbidity was reduced [168]. The role of antioxidants in preventing PTL in acute settings (i.e., peritonitis/intra-abdominal trauma) is unknown.
4.6.1.4 Inhibitors ofThrombin­mediated Contractions
Uterine trauma can cause nonplacental abruption uterine bleeding that activates thrombin. Thrombin causes uterine contractions even with­out prostaglandin synthesis (see Sect. 4.3.3.3). IV hirudin, a direct thrombin inhibitor, was used for other emergent indications in pregnancy and should be evaluated for this indication [169]. Another consideration is whether to administer r-hirudin as prophylactic therapy or only when uterine contractions are present and other causes for uterine contractions are excluded. The oral direct thrombin inhibitor, ximelagatran, was withdrawn due to potential hepatotoxicity [170]. This therapy could be contraindicated in trauma­induced uterine bleeding.
Thrombin-stimulated myometrial contrac­tions could be suppressed with inhibitors of the phosphatidylinositol signaling pathway [171].
4.6.1.5 Vitamin D
Maternal circulating 25-OHD deciency could increase overall PTL risk, and vitamin D supple­mentation alone during pregnancy could reduce PTB risk. The effect was signicant with mater­nal serum 25-OHD <50nmol/L [172]. Although not analyzed for pregnant patients with acute abdomen, vitamin D supplementation in the perioperative period could decrease the likeli­hood of PTL.
94
https://t.me/medicina_free
4 Acute Abdomen-Induced Preterm Labor
4.6.2 Tocolytic Treatment
Seventy years ago, it was stated that, when peri­tonitis is present, CS is mandatory [173175], and cesarean hysterectomy in more severe cases of abscess formation may prove lifesaving. Although preterm contractions caused by uterine irritation from peritonitis occur in up to 83% of the cases, PTL and delivery occur in only 5–14%. However, >50% of these patients in the third tri­mester deliver preterm [176]. True PTL can be dened as uterine contractions with transvaginal CL <20 mm, or CL 20–29 mm with a positive fetal fFN [177]. Threatened PTL is when a woman has symptoms of PTL, such as contrac­tions or cramping, but no cervical change, for example, a transvaginal CL 30mm.
Women with true PTL should receive tocolysis and corticosteroids. Despite symptoms, there is no need for therapy in threatened PTL, including tocolysis [177].
For patients with true PTL, tocolytic therapy can temporarily abolish contractions. However, it does not remove the underlying stimulus that ini­tiated the process of parturition or reverse partu­rition changes in the uterus and cervix. Prematurity is associated with adverse neonatal outcomes, while tocolytic agents can cause adverse neonatal effects. Between 23 and 26 completed weeks of gestation, each day of pro­longation of pregnancy increases the survival rate by 3% [178].
Prostaglandin inhibitors and calcium chan-
nel blockers are the tocolytics with the best
probability of 48h delay in all- cause PTL,
respiratory distress syndrome, neonatal
mortality, and maternal side effects [179].
The probability of postponed delivery for 48was highest with prostaglandin inhibitors (OR
5.39), followed by magnesium sulfate (OR 2.76), calcium channel blockers (OR 2.71), betamimet­ics (OR 2.41), and the oxytocin receptor blocker atosiban (OR 2.02) [179].
Tocolytic treatment after the onset of contrac­tions could not prevent PTL and should be ordered for patients with delayed presentation and advanced gestational age to prevent PTL and fetal loss [180]. Tocolysis only delays PTD for several days, but PTD is not prevented [181].
No study has documented positive effects on the outcome. The current recommendation is that using these agents is a matter of choice [182184].
SAGES and EAES guidelines recommend
tocolytics only if uterine contractions are
present.
Tocolytics could calm the uterus from the insult of the acute abdomen and the intraopera­tive uterine manipulation, but their benet is equivocal [185, 186]. There is no signicant dif­ference in the efcacy of different tocolytics or outcomes with or without tocolytics (Fig.4.10) [187]. Also, tocolytics have severe maternal and fetal side effects, which could contraindicate their use, especially ritodrine and prostaglandin synthetase inhibitors.
Ritodrine causes maternal and fetal tachycar­dia, nausea, and vomiting [188, 189], impairing important signs of the acute abdomen. Unlike ritodrine and prostaglandin synthetase inhibitors, nifedipine is safer and does not alter the disease symptomatology [185]. Nifedipine causes insig­nicant hypotension [189, 190]. The evidence for teratogenicity [191] is not conclusive [192], and no malformations were reported [188].
Nearly 26% with symptomatic cholelithiasis developed preterm contractions requiring tocoly­sis [193]. Tocolysis is used only if uterine con­tractions are present [194].
Maintenance Tocolysis: While acute tocolysis delays delivery of >48h and enables completion of antenatal corticosteroid administration and
35
Number of cases
prostaglandin
4.6 Treatment
https://t.me/medicina_free
Fig. 4.10 No statistically signicant difference between different tocolytics with their effect on the duration of pregnancy and prevention of preterm labor in the acute abdomen. (Reproduced with permission from [188])
95
30
25
20
15
Te rm Labor
Preterm Labor
Abortion
19
17
10
5
0
7
6
Ritodrine
5
2
1
Progesterone
patient’s transfer to a tertiary perinatal center, maintenance tocolysis is still controversial. So far, maintenance of tocolysis is a case-by-case decision outweighing its benets and harms (Table4.1).
4.6.2.1 Magnesium Sulfate
Magnesium is not metabolized, and elimination of the drug is conducted mainly through renal excretion. Therefore, the difference in clearance during and after pregnancy likely reects modi­cations in renal clearance. Pregnant women receiving magnesium sulfate for non­preeclamptic indications (i.e., neuroprotection and tocolysis) have an increased clearance of the drug compared with preeclamptic women [196].
Abdominal Trauma
Maternal trauma can cause PPROM and PTB, but is seldom an isolated event. At <24weeks of ges­tation, ROM may predispose the fetus to pulmo­nary hypoplasia or orthopedic deformities if the amniotic uid volume does not return to normal. With the injury to the placenta, bleeding may result in fetal anemia, hypovolemia, or both. Management is usually not different from spon­taneous ROM in the absence of maternal or fetal compromise.
2
1 1
Calcium Channel
Anti-
5
1 1
All Tocolytics No Drug
8
5
5
6
The use of tocolysis to treat PTL after blunt abdominal trauma is limited. Tocolysis is not rec­ommended because regular uterine activity after a traumatic event could result from a uterine con­tusion or placental abruption and these two diag­noses are indistinguishable [197]. There are cases of placental abruption with <1 uterine contrac­tion every 10min. In that population, almost 20% with frequent contractions had placental abrup­tion [197]. In noncatastrophic abdominal trauma in pregnancy, tocolysis for persistent contractions is reassuring after the maternal and fetal testing results [198].
Magnesium sulfate is the tocolytic agent of
choice for pregnant patients with abdomi-
nal trauma, with the added effect of fetal
neuroprotection to decrease the risk of
cerebral palsy. Minimal dose includes 4g
loading dose + 1 g/h maintenance dose
over 12h.
The PTL group received more magnesium sulfate tocolysis than the term birth group (31% vs. 7%, respectively). However, there were no differences in the gestational age at abdominal
96
https://t.me/medicina_free
Side effect
risk Recommendation
Improvement of
neonatal outcome
PTB
rate- reduction
decision
4 Acute Abdomen-Induced Preterm Labor
decision
No No Low Not recommended
Terbutaline, fenoterol, ritodrine No No High Not recommended
bolus, pump
Oral Nifedipine No No Intermediate Case-by-case
Oral/rectal/vaginal Indomethacin No No Intermediate Case-by-case
Substance class Administration route Substance
Beta-sympathomimetics Oral, parenteral:
Calcium-channel
blockers
Cyclooxygenase
inhibitors
Magnesium Oral/parenteral Magnesium sulfate No No Intermediate Not recommended
Table 4.1 Classes and substances for maintenance tocolysis
Nitric oxide donors Transdermal Nitroglycerine No No Intermediate Not recommended
Micronized progesterone,
17α-hydroxyprogesterone caproate
Parenteral Atosiban No No Low Not recommended
Oxytocin receptor
intramuscular
antagonists
Progesterone Oral/vaginal
Reproduced with permission from [195]
8
Time (hours)
Magnesium concentration (mg/dL)
Wt
4.6 Treatment
https://t.me/medicina_free
97
trauma and the interval between trauma and delivery between groups. In abdominal trauma, patients with PTB had a closed and no effaced cervix at the time of abdominal trauma [198]. Magnesium sulfate in non-acute abdomen PTL is neuroprotective. It improves long-term neonatal health outcomes, despite maternal side effects (decreases respiratory efforts and, in high doses, may lead to hypotension, respiratory collapse, or cardiac arrhythmias). While magnesium sulfate has not signicantly improved cognition and behavior outcomes at school age, it prevents cerebral palsy at 2years [199]. The most bene­cial dosing regimen for neuroprotection remains unknown [196]. Magnesium readily crosses the placenta, with an almost 1:1 ratio of magnesium in the pregnant mother and umbilical cord [200]. Magnesium levels increase in fetal serum within 1h and amniotic uid within 3h after maternal IV administration [200]. Among pregnant women with preeclampsia, serum magnesium levels were signicantly greater during magnesium sul­fate infusion than non-preeclamptic women receiving the same magnesium sulfate dosing. Women with the greatest body weight had lower serum magnesium levels after the bolus adminis­tration of magnesium sulfate than women with the lowest body weight (Fig.4.11).
Several classes of tocolytic agents are not rec­ommended in abdominal trauma. Betamimetics (β2-adrenergic agonists) cause maternal and fetal
tachycardia. They can mask the clinical signs of hypovolemia in both the mother and the fetus, leading to a delay in the institution of the appro­priate intervention. NSAIDs/Indomethacin affect platelet function and are contraindicated in patients with head injury or occult bleeding. Calcium channel blockers may produce hypoten­sion. Such vital sign changes mimic those seen in occult hemorrhage, mandating close monitoring.
Renal Colic
Although controversial, magnesium sulfate could have combined benecial effects in patients with renal colic or renal collecting system rupture [201, 202]:
• tocolysis,
• ureteric muscle relaxation,
• direct pain relief,
• decreased formation and progression of some forms of renal stones.
Ureteric muscle relaxations relieve pain and
magnesium sulfate directs pain relief on the molecular level. It is a noncompetitive antagonist of N-methyl-d-aspartate (NMDA) glutamate receptors that participate in pain feeling and per­sistence. These pain relief effects can result in lesser use of other analgesics. Magnesium is a urinary stone inhibitor because it competes with calcium for oxalate, thus forming a magnesium-
Fig. 4.11 Magnesium serum concentration after 4g loading dose of magnesium sulfate, followed by 2g/h infusion among pregnant women with and without preeclampsia and women of lowest (55kg), mean (88kg), and greatest (157kg) body weights. (Reproduced with permission from [196])
7
6
5
4
3
2
1
0510 15 20 25
Low Wt
Mean Wt
High Wt
Preeclampsia Low Wt
Preeclampsia Mean
Preeclampsia High Wt
30 35 40 45 50 55 60